Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06047366 · ClinicalTrials.gov registry record · Phase 4
Combination of Buffered Anesthetic to Treat Mandibular Molars
A Phase 4 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT06047366 is a Phase 4 study that was terminated before completion, run by Indiana University. The registered enrollment target is 40 participants.
The verdict
NCT06047366, a Phase 4 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a combination of anesthetics (numbing medicine) will adequately anesthetize teeth over a different combination. A second purpose is to see if the time needed to numb the nerve in a tooth is different between the two anesthetics.
Interventions
- DRUG Sodium bicarbonate
- DRUG Lidocaine w/ epi
- DRUG Articaine w/ epi
- DRUG Mepivacaine plain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-12-05 |
| Est. Completion | 2024-05-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06047366
The ClinicalTrials.gov registry entry for NCT06047366 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Sodium bicarbonate is the first listed.
NCT06047366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06047366 about?
NCT06047366 is a clinical study titled "Combination of Buffered Anesthetic to Treat Mandibular Molars". The purpose of this study is to determine whether a combination of anesthetics (numbing medicine) will adequately anesthetize teeth over a different combination. A second purpose is to see if the time needed to numb the nerve in a tooth is different between the two anesthetics.
What is the current status of trial NCT06047366?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2023-12-05. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT06047366?
The interventions under investigation include: Sodium bicarbonate (DRUG), Lidocaine w/ epi (DRUG), Articaine w/ epi (DRUG), Mepivacaine plain (DRUG).
Who is sponsoring clinical trial NCT06047366?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.